MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporat...

by Scheerens, Heleen, Su, Zheng, Irving, Bryan, Townsend, Michael J, Zheng, Yanan, Stefanich, Eric, Chindalore, Vishala, Bingham, Clifton O, Davis, John C
Published 2011

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

by Hanania, Nicola A, Noonan, Michael, Corren, Jonathan, Korenblat, Phillip, Zheng, Yanan, Fischer, Saloumeh K, Cheu, Melissa, Putnam, Wendy S, Murray, Elaine, Scheerens, Heleen, Holweg, Cecile TJ, Maciuca, Romeo, Gray, Sarah, Doyle, Ramona, McClintock, Dana, Olsson, Julie, Matthews, John G, Yen, Karl
Published 2015

A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma

by Harris, Jeffrey M., Maciuca, Romeo, Bradley, Mary S., Cabanski, Christopher R., Scheerens, Heleen, Lim, Jeremy, Cai, Fang, Kishnani, Mona, Liao, X. Charlene, Samineni, Divya, Zhu, Rui, Cochran, Colette, Soong, Weily, Diaz, Joseph D., Perin, Patrick, Tsukayama, Miguel, Dimov, Dimo, Agache, Ioana, Kelsen, Steven G.
Published 2016